Circulating ceramide ratios and risk of vascular brain aging and dementia
Abstract Background We determined the association between ratios of plasma ceramide species of differing fatty‐acyl chain lengths and incident dementia and Alzheimer’s disease (AD) dementia in a large, community‐based sample. Methods We measured plasma ceramide levels in 1892 [54% women, mean age 70...
Main Authors: | Emer R. McGrath, Jayandra J. Himali, Vanessa Xanthakis, Meredith S. Duncan, Jean E. Schaffer, Daniel S. Ory, Linda R. Peterson, Charles DeCarli, Matthew P. Pase, Claudia L. Satizabal, Ramachandran S. Vasan, Alexa S. Beiser, Sudha Seshadri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.50973 |
Similar Items
-
Circulating IGFBP‐2: a novel biomarker for incident dementia
by: Emer R. McGrath, et al.
Published: (2019-09-01) -
Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia
by: Emer R. McGrath, et al.
Published: (2020-10-01) -
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
by: Emer R McGrath, et al.
Published: (2019-01-01) -
Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
by: Honghuang Lin, et al.
Published: (2022-04-01) -
Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
by: José Rafael Romero, et al.
Published: (2020-07-01)